Coherus Oncology, Inc. SEC filings CHRS
Coherus Oncology, Inc. has 921 filings in SEC EDGAR's recent list, going back to Feb 23, 2011. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 29, 2026 | Oct 28, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| 424B5 | Prospectus supplement | Aug 28, 2026 | — |
| 424B3 | Prospectus | Aug 28, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Aug 17, 2026 | Aug 17, 2026 |
| S-8 | Employee stock plan registration | Aug 5, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 8-K |
Current report
Auditor change
|
Jun 15, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 9, 2026 | Jun 5, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 4 | Insider transaction | Jun 2, 2026 | May 29, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2026 | May 27, 2026 |
| DEFA14A | Additional proxy material | May 28, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 11, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 11, 2026 | May 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| DEFA14A | Additional proxy material | May 5, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 29, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| ARS | Annual report to shareholders | Apr 20, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 20, 2026 | May 27, 2026 |
| DEFA14A | Additional proxy material | Apr 14, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 9, 2026 | May 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2026 | Mar 9, 2026 |
| 8-K |
Current report
Other events
|
Feb 17, 2026 | Feb 12, 2026 |
| 424B5 | Prospectus supplement | Feb 13, 2026 | — |
| 424B5 | Prospectus supplement | Feb 12, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 4, 2026 | Feb 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 30, 2026 | — |
| 4 | Insider transaction | Jan 26, 2026 | Jan 23, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Other events
|
Jan 23, 2026 | Jan 23, 2026 |
| 424B5 | Prospectus supplement | Jan 23, 2026 | — |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2026 | Jan 13, 2026 |
| EFFECT | Filing | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 5, 2025 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| S-8 | Employee stock plan registration | Nov 13, 2025 | — |
| 8-K |
Current report
Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 4, 2025 | — |
| 8-K |
Current report
Other events
|
Sep 8, 2025 | Sep 5, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 3, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
May 30, 2025 | May 29, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| SC TO-I/A | Filing | May 15, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| 4 | Insider transaction | May 9, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2025 | Apr 22, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2025 | Apr 16, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 16, 2025 | — |
| SC TO-I | Filing | Apr 16, 2025 | — |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Apr 14, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 1, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 13, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2025 | Mar 10, 2025 |
| DEFA14A | Additional proxy material | Mar 4, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 4, 2025 | Mar 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| DEFA14A | Additional proxy material | Jan 30, 2025 | — |
| DEFM14A | Filing | Jan 28, 2025 | — |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Jan 20, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| PREM14A | Filing | Jan 14, 2025 | Jan 10, 2025 |
| DEFA14A | Additional proxy material | Jan 14, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 4, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 4, 2024 | Nov 27, 2024 |
| DEFA14A | Additional proxy material | Dec 4, 2024 | — |
| DEFA14A | Additional proxy material | Dec 4, 2024 | — |
| DEFA14A | Additional proxy material | Dec 3, 2024 | — |
| DEFA14A | Additional proxy material | Dec 3, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Dec 3, 2024 | Dec 2, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 13, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2024 | Sep 13, 2024 |
| UPLOAD | Letter from the SEC | Sep 13, 2024 | — |
| CORRESP | Letter to the SEC | Sep 6, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2024 | — |
| 4 | Insider transaction | Aug 9, 2024 | Aug 7, 2024 |
| S-8 | Employee stock plan registration | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 8, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| 4 | Insider transaction | Jul 24, 2024 | Jul 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 23, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jul 2, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Other events
|
Jun 27, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 4, 2024 |
| 3 | Initial insider ownership | Jun 5, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2024 | May 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2024 | May 29, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | May 22, 2024 | — |
| 8-K/A | Amended current report | May 21, 2024 | May 8, 2024 |
| DEFA14A | Additional proxy material | May 13, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
May 9, 2024 | May 8, 2024 |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 15, 2024 | — |
| DEF 14A | Proxy statement | Apr 15, 2024 | May 29, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Mar 4, 2024 | Mar 1, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| 3 | Initial insider ownership | Feb 22, 2024 | Feb 20, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 22, 2024 | Feb 20, 2024 |
| 4 | Insider transaction | Feb 15, 2024 | Feb 9, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 4 | Insider transaction | Feb 5, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 5, 2024 | Feb 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 24, 2024 | — |
| 4 | Insider transaction | Jan 23, 2024 | Jan 20, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 20, 2024 |
| 4 | Insider transaction | Jan 23, 2024 | Jan 20, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 22, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Results of operations
|
Jan 10, 2024 | Jan 10, 2024 |
| 8-K |
Current report
Other events
|
Jan 10, 2024 | Jan 10, 2024 |
| 4 | Insider transaction | Jan 9, 2024 | Jan 7, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 8, 2024 | Jan 4, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 3, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Dec 27, 2023 | Dec 26, 2023 |
| 4 | Insider transaction | Dec 15, 2023 | Dec 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 11, 2023 | Dec 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 7, 2023 | Dec 7, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 7, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 27, 2023 | Nov 27, 2023 |
| 4 | Insider transaction | Nov 24, 2023 | Nov 22, 2023 |
| 144 | Notice of proposed sale | Nov 22, 2023 | — |
| 8-K/A | Amended current report | Nov 13, 2023 | Sep 8, 2023 |
| 10-Q | Quarterly report | Nov 6, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K/A | Amended current report | Nov 6, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 27, 2023 | Oct 27, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 27, 2023 | Oct 24, 2023 |
| 8-K |
Current report
Unregistered share sale
|
Oct 6, 2023 | Oct 4, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 6, 2023 | — |
| 8-K |
Current report
Material agreement
|
Sep 12, 2023 | Sep 11, 2023 |
| 424B5 | Prospectus supplement | Sep 12, 2023 | — |
| 8-K |
Current report
Acquisition or sale of assets, Other events
|
Sep 8, 2023 | Sep 8, 2023 |
| 10-Q | Quarterly report | Aug 2, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2023 | Aug 2, 2023 |
| EFFECT | Filing | Jul 26, 2023 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CHRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1512762
- Former names
- Coherus BioSciences, Inc. (until May 28, 2025); BioGenerics, Inc. (until Jan 3, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.